1021871-36-2

Basic information

• Product Name: 3-(broMoMethyl)-5-chlorobenzonitrile
• Synonyms: 3-(broMoMethyl)-5-chlorobenzonitrile
• CAS NO: 1021871-36-2
• Molecular Formula: C₈H₅BrClN
• Molecular Weight: 230.489
• EINECS: -0
• Mol File: 1021871-36-2.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-(broMoMethyl)-5-chlorobenzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(broMoMethyl)-5-chlorobenzonitrile(1021871-36-2)
• EPA Substance Registry System: 3-(broMoMethyl)-5-chlorobenzonitrile(1021871-36-2)

Safety Data

• Hazardous Substances Data: 1021871-36-2(Hazardous Substances Data)

Upstream product

• 189161-09-9 3-chloro-5-methylbenzonitrile 
• 1021871-35-1 3-Chloro-5-(hydroxymethyl)benzonitrile 

Downstream Products

• 1021873-81-3 5-chloro-1-(3-chloro-5-cyanobenzyl)-2-imino-1,2-dihydropyridine-3-carboxamide monohydrobromide 
• 1205513-85-4 acetic acid 3-chloro-5-cyano-benzyl ester 

Relevant articles and documents

COMPOUNDS AND USES THEREOF

The present invention features compounds useful in the treatment of neurological disorders and primary brain cancer. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders and primary brain cancer.

N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS

A compound of formula (I), or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising the compound. The compound is an inhibitor of interactions between S100A9 and interaction partners such as RAGE, TLR4 and EMMPRIN and as such is useful in the treatment of disorders such as cancer, autoimmune disorders, inflammatory disorders and neurodegenerative disorders.

OXADIAZOLE DERIVATIVES

The invention relates to compounds of formula (I); wherein R1, R2, Ra, Rb, W, Q and S have the meanings given in claim 1. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple